PAPER Chiba Y, Komori H, Takei S, Hasegawa-Ishii S, Kawamura N, Adachi K, Nanba E, Hosokawa M, Enokido Y, Kouchi Z, Yoshida F, Shimada A
SEARCH RESULTS
331159 RESULTS
PAPER Krakora D, Mulcrone P, Meyer M, Lewis C, Bernau K, Gowing G, Zimprich C, Aebischer P, Svendsen CN, Suzuki M
Synergistic Effects of GDNF and VEGF on Lifespan and Disease Progression in a Familial ALS Rat Model.
Mol Ther. 2013 Aug;21(8):1602-10. PubMed: 23712039PAPER Bourdenx M
Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease.
Mov Disord. 2013 Jun;28(6):736. PubMed: 23712582PAPER Harrison IF, Dexter DT
Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease?
Pharmacol Ther. 2013 May 24; PubMed: 23711791PAPER Tarragon E, Lopez D, Estrada C, Ana GC, Schenker E, Pifferi F, Bordet R, Richardson JC, Herrero MT
Octodon degus: A Model for the Cognitive Impairment Associated with Alzheimer's Disease.
CNS Neurosci Ther. 2013 Sep;19(9):643-8. PubMed: 23710760PAPER Clare L, Bayer A, Burns A, Corbett A, Jones R, Knapp M, Kopelman M, Kudlicka A, Leroi I, Oyebode J, Pool J, Woods B, Whitaker R
Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT).
Trials. 2013;14:152. PubMed: 23710796PAPER Peters KR
Utility of an effect size analysis for communicating treatment effectiveness: a case study of cholinesterase inhibitors for Alzheimer's disease.
J Am Geriatr Soc. 2013 Jul;61(7):1170-4. PubMed: 23711226PAPER Noh MY, Koh SH, Kim SM, Maurice T, Ku SK, Kim SH
Neuroprotective effects of donepezil against Aβ42-induced neuronal toxicity are mediated through not only enhancing PP2A activity but also regulating GSK-3β and nAChRs activity.
J Neurochem. 2013 May 25; PubMed: 23711227PAPER McInnes J
Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration.
Transl Neurodegener. 2013;2(1):12. PubMed: 23711354PAPER Duan Z, Sesti F
A Caenorhabditis elegans Model System for Amylopathy Study.
J Vis Exp. 2013;(75) PubMed: 23711592PAPER Blaney CE, Gunn RK, Stover KR, Brown RE
Maternal genotype influences behavioral development of 3×Tg-AD mouse pups.
Behav Brain Res. 2013 Sep 1;252:40-8. PubMed: 23711927PAPER Kennedy RE, Cutter GR, Schneider LS
Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
Alzheimers Dement. 2014 May;10(3):349-59. Epub 2013 May 25 PubMed: 23712001PAPER van Rooden S, Versluis MJ, Liem MK, Milles J, Maier AB, Oleksik AM, Webb AG, van Buchem MA, van der Grond J
Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker.
Alzheimers Dement. 2013 May 25; PubMed: 23712002PAPER Miller LA, Mioshi E, Savage S, Lah S, Hodges JR, Piguet O
Identifying cognitive and demographic variables that contribute to carer burden in dementia.
Dement Geriatr Cogn Disord. 2013;36(1-2):43-9. PubMed: 23712244PAPER Zhang C, Nestorova G, Rissman RA, Feng J
Detection and quantification of 8-hydroxy-2'-deoxyguanosine in Alzheimer's transgenic mouse urine using capillary electrophoresis.
Electrophoresis. 2013 Aug;34(15):2268-74. PubMed: 23712533Current Filters
No filters selected